Philippe Gannon

Philippe Gannon currently serves as a Scientist and Postdoctoral Fellow at the Lausanne University Hospital (CHUV), where he is deeply engaged in advancing cell-based cancer therapies through GMP manufacturing. In his role, Philippe leverages his extensive expertise in immunology, oncology, and GMP-compliant technologies to develop and optimize innovative therapeutic strategies aimed at improving patient outcomes. His work involves overseeing critical aspects of the production process within the Centre of Experimental Therapeutics, ensuring strict adherence to GMP standards for the manufacturing of personalized cell therapies, including CAR-T cells and other immune effector cells.

A key focus of Philippe’s research is the integration of cutting-edge genetic analysis, real-time PCR, and cell culture techniques to enhance the efficacy and safety of these therapies. His leadership in managing the GMP facilities and logistics unit underscores his ability to coordinate complex operations, streamline workflows, and foster a collaborative environment among multidisciplinary teams. Philippe’s proactive approach and results-driven mindset have contributed to successful project milestones, such as the development of scalable manufacturing protocols and quality assurance processes.

With a strong foundation in cell biology, cancer research, and life sciences, Philippe Gannon is committed to translating scientific innovations into clinical applications. His role at CHUV not only involves hands-on technical expertise but also strategic planning and management, positioning him as a key contributor to the hospital’s pioneering efforts in personalized oncology treatments. His proven leadership skills and scientific acumen make him a vital asset in the evolving landscape of cell-based immunotherapies.